hematopoietic system
| N |
• the blood of both homozygous and heterozygous mutant mice contains normal numbers of CD4+ T cells, CD19+ B cells and CD11c+ dendritic cells
|
|
• the bloood of heterozygous mutant mice contains a reduced number of NK1.1+ cells, intermediate between those of wild-type and of homozygous mutant mice
|
|
• the bloood of heterozygous mutant mice contains a reduced number of CD8+ cells, intermediate between those of wild-type and of homozygous mutant mice
|
|
• natural killer (NK) cells from previously immunized heterozygous mutant mice exhibit diminished ability to kill class I MHC-deficient cells in vivo; the level of killing is intermediate between that of wild-type and of homozygous mutant mice
|
immune system
| N |
• the blood of both homozygous and heterozygous mutant mice contains normal numbers of CD4+ T cells, CD19+ B cells and CD11c+ dendritic cells
• CD8+ cytotoxic T lymphocytes (CTL) from previously immunized homozygus and heterozygous mutant mice exhibit normal ability of to kill antigen-specific target cells in vivo
|
|
• the bloood of heterozygous mutant mice contains a reduced number of NK1.1+ cells, intermediate between those of wild-type and of homozygous mutant mice
|
|
• the bloood of heterozygous mutant mice contains a reduced number of CD8+ cells, intermediate between those of wild-type and of homozygous mutant mice
|
|
• natural killer (NK) cells from previously immunized heterozygous mutant mice exhibit diminished ability to kill class I MHC-deficient cells in vivo; the level of killing is intermediate between that of wild-type and of homozygous mutant mice
|
|
• heterozygous mutants exhibit enhanced susceptibility to infection with 2 x 105 PFU of mouse cytomegalovirus (MCMV)
|


Analysis Tools